Re: Biodel's VIAject ultra rapid acting insulin

Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BobW

Rank: Vice President [?]

Points: 1080 [?]

Votes: 11 Score: 4.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Biodel's VIAject ultra rapid acting insulin

in response to

Biodel's VIAject ultra rapid acting insulin

BobW

posted on Nov 12, 2012 09:40PM

From their web-site: We now intend to study BIOD-123 in a Phase 2 clinical trial that we expect to begin in the third calendar quarter of 2012.

If successful, it is conceivable that it could be approved in a few years. Even if this is after Afrezza, it would make it harder for Afrezza to ramp up to its potential market share.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply